The German Hodgkin Study Group risk model is useful for Hodgkin lymphoma patients receiving radiotherapy after autologous stem cell transplant

Furlan C.; Matrone F.; Rupolo M.; Ciancia R.; Zanet E.; Montante B.; Palazzari E.; Navarria F.; Trovo M.; Bulian P.; Spina M.; Coassin E.; Mascarin M.; De Paoli A.; Franchin G.; Michieli M.

首页> 外文期刊>Cancer radiotherapie: journal de la Soci閠?fran鏰ise de radiotherapie oncologique >The German Hodgkin Study Group risk model is useful for Hodgkin lymphoma patients receiving radiotherapy after autologous stem cell transplant

【24h】

The German Hodgkin Study Group risk model is useful for Hodgkin lymphoma patients receiving radiotherapy after autologous stem cell transplant

机译：德国霍奇金研究组风险模型对于自体干细胞移植后接受放射治疗的霍奇金淋巴瘤患者有用

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Purpose. - To apply the German Hodgkin Study Group (GHSG) risk model in patients with recurrent/refractory Hodgkin lymphoma receiving involved-field radiotherapy after autologous stem cell transplantation.

机译：目的。 - 在自体干细胞移植后接受涉及场放射疗法接受涉及场放射患者的德国Hodgkin研究组（GHSG）风险模型。

著录项

来源
《Cancer radiotherapie: journal de la Soci閠?fran鏰ise de radiotherapie oncologique》 |2019年第5期|共7页
作者
Furlan C.; Matrone F.; Rupolo M.; Ciancia R.; Zanet E.; Montante B.; Palazzari E.; Navarria F.; Trovo M.; Bulian P.; Spina M.; Coassin E.; Mascarin M.; De Paoli A.; Franchin G.; Michieli M.;
展开▼
作者单位

IRCCS Ctr Riferimento Oncol Aviano CRO Radiat Oncol I-33081 Aviano Italy;

IRCCS Ctr Riferimento Oncol Aviano CRO Radiat Oncol I-33081 Aviano Italy;

IRCCS Ctr Riferimento Oncol Aviano CRO Unit Cell Therapy &

High Dose Chemotherapy I-33081 Aviano;

IRCCS Ctr Riferimento Oncol Aviano CRO Unit Cell Therapy &

High Dose Chemotherapy I-33081 Aviano;

IRCCS Ctr Riferimento Oncol Aviano CRO Unit Cell Therapy &

High Dose Chemotherapy I-33081 Aviano;

IRCCS Ctr Riferimento Oncol Aviano CRO Unit Cell Therapy &

High Dose Chemotherapy I-33081 Aviano;

IRCCS Ctr Riferimento Oncol Aviano CRO Radiat Oncol I-33081 Aviano Italy;

IRCCS Ctr Riferimento Oncol Aviano CRO Radiat Oncol I-33081 Aviano Italy;

Udine Gen Hosp Radiat Oncol I-33010 Udine Italy;

IRCCS Ctr Riferimento Oncol Aviano CRO Clin &

Expt Oncohematol Unit I-33081 Aviano Italy;

IRCCS Ctr Riferimento Oncol Aviano CRO Med Oncol A I-33081 Aviano Italy;

IRCCS Ctr Riferimento Oncol Aviano CRO Pediat Radiotherapy Unit I-33081 Aviano Italy;

IRCCS Ctr Riferimento Oncol Aviano CRO Pediat Radiotherapy Unit I-33081 Aviano Italy;

IRCCS Ctr Riferimento Oncol Aviano CRO Radiat Oncol I-33081 Aviano Italy;

IRCCS Ctr Riferimento Oncol Aviano CRO Radiat Oncol I-33081 Aviano Italy;

IRCCS Ctr Riferimento Oncol Aviano CRO Unit Cell Therapy &

High Dose Chemotherapy I-33081 Aviano;

展开▼
收录信息
原文格式 PDF
正文语种 fre
中图分类肿瘤学;
关键词
Transplant; Radiotherapy; Recurrent; Hodgkin lymphoma;

机译：移植;放疗;复发;霍奇金淋巴瘤;

相似文献

外文文献
中文文献
专利

1. 德国霍奇金淋巴瘤研究小组报告:原发性霍奇金病继发非霍奇金淋巴瘤的发病率、治疗及预后 [J] . U.Rueffer, 张玉平, 等中德临床肿瘤学杂志（英文版） . 2001,第006期
2. The German Hodgkin Study Group risk model is useful for Hodgkin lymphoma patients receiving radiotherapy after autologous stem cell transplant [J] . Furlan C., Matrone F., Rupolo M., Cancer radiotherapie: journal de la Soci閠?fran鏰ise de radiotherapie oncologique . 2019,第5期

机译：德国霍奇金研究组风险模型对于自体干细胞移植后接受放射治疗的霍奇金淋巴瘤患者有用
3. A Prospective, Multicenter Study of Involved-Field Radiation Therapy With Autologous Stem Cell Transplantation for Patients With Hodgkin Lymphoma and Aggressive Non-Hodgkin Lymphoma (ALLG HDNHL04/TROG 03.03) [J] . Wirth Andrew, Prince H. Miles, Roos Daniel, International Journal of Radiation Oncology, Biology, Physics . 2019,第5期

机译：霍奇金淋巴瘤患者自体干细胞移植治疗涉及 - 场放射治疗的预期，多中心研究，伴有侵略性非霍奇金淋巴瘤（allg HDNHL04 / TROG 03.03）
4. Rituximab therapy increased post-transplant cytomegalovirus complications in Non-Hodgkin’s lymphoma patients receiving autologous hematopoietic stem cell transplantation [J] . Ming-Yang Lee, Tzeon-Jye Chiou, Liang-Tsai Hsiao, Annals of Hematology . 2008,第4期

机译：利妥昔单抗治疗增加了接受自体造血干细胞移植的非霍奇金淋巴瘤患者的移植后巨细胞病毒并发症
5. Unusual Presentations of Central Nervous System Non-Hodgkin and Hodgkin Lymphoma: A Clinicopathologic Review of Four Tumours [C] . Lee HY, Chuah KL, Ng SB, International Congress of Neuropathology . 2010

机译：中枢神经系统非霍奇金和霍格金淋巴瘤的不寻常介绍：对四种肿瘤的临床病理综述
6. Characterization of gamma herpesvirus viral DNA in peripheral blood of patients with virus-associated malignancies and analysis of CD8+ T cell responses to viral antigens in patients with Hodgkin's lymphoma. [D] . Lin, Lan. 2005

机译：霍乱金淋巴瘤患者病毒相关恶性肿瘤患者外周血中γ疱疹病毒DNA的表征以及CD8 + T细胞对病毒抗原的应答分析。
7. Prognostic value of pre- and post-transplantation 18F-fluorodeoxyglucose positron emission tomography results in non-Hodgkin lymphoma patients receiving autologous stem cell transplantation [O] . Zhitao Ying, Lan Mi, Xuejuan Wang, 2017

机译：移植前后18F-氟脱氧葡萄糖正电子发射断层扫描对非霍奇金淋巴瘤患者接受自体干细胞移植的预后价值
8. Gemcitabine, Busulfan and Melphalan (Gem/Bu/Mel) Is a New High-Dose Chemotherapy (HDC) Regimen with High Activity in Refractory or Poor-Risk Relapsed Non-Hodgkin'S Lymphoma (NHL) Patients Receiving an Autologous Stem-Cell Transplant (ASCT) [O] . Nieto Y., Jones R.B., Popat U., 2012

机译：吉西他滨，白消安和美法仑（Gem / Bu / Mel）是一种新型的高剂量化学疗法（HDC）方案，在接受自体干细胞移植（ASCT）的难治性或低危复发非霍奇金淋巴瘤（NHL）患者中具有高活性）

The German Hodgkin Study Group risk model is useful for Hodgkin lymphoma patients receiving radiotherapy after autologous stem cell transplant

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅